Management of chronic pain in children and young people: summary
A summary of the available evidence, combined with a consensus group agreement on key recommendations and suggested patient pathways.
Appendix 2: Key questions
1. In patients with chronic non-malignant pain being managed is there any evidence that timing of referral or treatment impacts on outcomes?
2. In patients with chronic non-malignant pain is there any evidence that the nature of interaction with healthcare professionals, education system and parents affects patient outcomes?
3. In patients with chronic non-malignant pain are opioids effective compared with placebo or other interventions in pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events/drug reactions, dependency (physiological or psychological).
4. In patients with chronic non-malignant pain what are the most effective simple analgesics compared with placebo or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events/drug reactions, dependency (physiological or psychological).
5. In patients with chronic non-malignant pain what is the effectiveness of anticonvulsants compared with placebo or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse drug reactions, dependency (physiological or psychological).
6. In patients with chronic non-malignant pain what is the effectiveness of topical analgesics compared with placebo or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events/drug reactions, dependency (physiological or psychological)?
7. In patients with chronic non-malignant pain what is the effectiveness of antidepressants compared with placebo or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events/drug reactions, dependency (physiological or psychological).
8. In patients with chronic non-malignant pain what is the effectiveness of non-standard analgesics compared with placebo or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events/drug reactions, dependency (physiological or psychological).
9. In patients with chronic non-malignant pain what is the effectiveness of physical therapies compared with no physical therapy or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events.
10. In patients with chronic non-malignant pain what is the effectiveness of complementary and alternative therapies compared with no treatment or other interventions on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events.
11. In patients with chronic non-malignant pain what is the effectiveness of expert/clinician guided self-help management advice/ programmes/psychological treatments compared with no treatment or other interventions on pain scores, functional ability, mood, QoL and adverse events.
12. In patients with chronic non-malignant pain is there any evidence for the effectiveness of dietary interventions compared with usual care on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events.
13. In patients with chronic non-malignant pain what is the effectiveness of surgery, nerve blocks compared with no intervention on pain scores (30% reduction and 50% reduction), functional ability, quality of life, adverse events.
Contact
There is a problem
Thanks for your feedback